Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19880495 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Condition: Epstein-Barr Virus Infections
Intervention: Biological: EBV specific T cells

Study has passed its completion date and status has not been verified in more than two years.